Document Detail


Docosahexaenoic Acid Prevents Trans-10, Cis-12-Conjugated Linoleic Acid-Induced Nonalcoholic Fatty Liver Disease in Mice by Altering Expression of Hepatic Genes Regulating Fatty Acid Synthesis and Oxidation.
MedLine Citation:
PMID:  22242926     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background: Concomitant supplementation with docosahexaenoic acid (22:6 n-3; DHA) prevented trans-10, cis-12-conjugated linoleic acid (CLA)-induced nonalcoholic fatty liver disease (NAFLD) and insulin resistance. The effective dose of DHA and mechanisms involved are poorly understood. Methods: We examined the ability of DHA (0.5% and 1.5%) to prevent increases in NAFLD and homeostatic model assessment of insulin resistance (HOMA-IR) induced by CLA (0.5%) when fed concomitantly for 4 weeks to C57BL/6N female mice. We also examined changes in expression of hepatic genes involved in fatty acid synthesis and oxidation. Results: CLA supplementation increased liver triglycerides (TG) and HOMA-IR by 221% and 547%, respectively, and decreased mass of different adipose depots by 65%-90% when compared to those in the control group. When fed concomitantly, DHA prevented CLA-induced increases in liver TG and circulating insulin with varying efficiency, but it did not prevent loss in adipose tissue mass. In the CLA+0.5% DHA group, the liver TG did not differ from those in the control group, but circulating insulin and HOMA-IR were 285% and 264%, respectively. In the CLA+1.5% DHA group, liver TG were 54% lower than those in the control group, but circulating insulin concentration and HOMA-IR did not differ between these two groups. CLA increased the expression of hepatic genes involved in fatty acid synthesis and decreased the expression of genes involved in fatty acid oxidation, and 1.5% DHA prevented changes in the expression of hepatic genes caused by CLA. Conclusions: Response of different tissues to CLA and DHA varied; CLA was more potent than DHA in altering depot fat and insulin concentrations.
Authors:
Dawn M Fedor; Yuriko Adkins; Bruce E Mackey; Darshan S Kelley
Related Documents :
22024496 - Omega-3 fatty acid deficiency selectively up-regulates delta6-desaturase expression and...
10813596 - Ontogenesis of cyp2c-dependent arachidonic acid metabolism in the human liver: relation...
15752706 - Inhibition of cox activity by nsaids or ascorbate increases camp levels and enhances di...
21827226 - Authentication analysis of cod liver oil from beef fat using fatty acid composition and...
18461316 - Impact of polyunsaturated fatty acid degradation on survival and acidification activity...
17919646 - Thermodynamics of hydrophobic interaction chromatography of acetyl amino acid methyl es...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-13
Journal Detail:
Title:  Metabolic syndrome and related disorders     Volume:  -     ISSN:  1557-8518     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101150318     Medline TA:  Metab Syndr Relat Disord     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Western Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture and Department of Nutrition, University of California Davis , Davis, California.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Patterning and Electronic Tuning of Laser Scribed Graphene for Flexible All-Carbon Devices.
Next Document:  Meat Consumption, Cooking Methods, Mutagens, and Risk of Squamous Cell Carcinoma of the Esophagus: A...